Curaleaf Holdings, Inc.
General ticker "CURLF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.6B (TTM average)
Curaleaf Holdings, Inc. follows the US Stock Market performance with the rate: 47.1%.
Estimated limits based on current volatility of 5.5%: low 3.21$, high 3.59$
Factors to consider:
- Earnings expected soon, date: 2026-05-05 amc
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.86$, 4.36$]
- 2026-12-31 to 2027-12-31 estimated range: [1.48$, 3.56$]
Financial Metrics affecting the CURLF estimates:
- Positive: with PPE of -12.4 at the end of fiscal year the price was neutral
- Positive: -4.72 < Operating profit margin, % of 2.01
- Positive: 19.49 < Shareholder equity ratio, % of 26.58 <= 42.60
- Positive: -4.45 < Investing cash flow per share per price, % of -3.16
- Positive: 0.07 < Operating cash flow per share per price, % of 6.18
- Negative: Industry inventory ratio change (median), % of 0.52 > 0.31
- Negative: Interest expense per share per price, % of 4.52 > 3.29
Short-term CURLF quotes
Long-term CURLF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,371.33MM | $1,278.33MM | $1,290.33MM |
| Operating Expenses | $1,327.66MM | $1,259.10MM | $1,264.44MM |
| Operating Income | $43.67MM | $19.23MM | $25.90MM |
| Non-Operating Income | $-170.32MM | $-131.21MM | $-105.48MM |
| Interest Expense | $100.38MM | $100.62MM | $102.59MM |
| Income(Loss) | $-126.65MM | $-111.98MM | $-79.58MM |
| Taxes | $116.69MM | $93.86MM | $125.85MM |
| Profit(Loss)* | $-286.35MM | $-226.73MM | $-235.12MM |
| Stockholders Equity | $1,045.27MM | $860.70MM | $754.97MM |
| Inventory | $214.81MM | $220.52MM | $0.00MM |
| Assets | $3,080.73MM | $2,947.78MM | $2,840.14MM |
| Operating Cash Flow | $76.64MM | $154.76MM | $140.35MM |
| Capital expenditure | $66.65MM | $88.68MM | $64.55MM |
| Investing Cash Flow | $-75.89MM | $-89.32MM | $-71.80MM |
| Financing Cash Flow | $-72.49MM | $-51.63MM | $-74.78MM |
| Earnings Per Share** | $-0.40 | $-0.31 | $-0.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.